dorsaVi Ltd. | Cash Flow

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
3,562.00
8,036.20
5,237.10
3,876.20
-
Depreciation, Depletion & Amortization
42.00
87.60
115.90
174.70
-
Other Funds
6.00
38.30
56.40
40.20
14.70
Funds from Operations
3,436.00
7,912.60
4,768.50
2,959.60
2,597.40
Changes in Working Capital
257.00
22.60
1,179.40
427.10
-
Net Operating Cash Flow
3,179.00
7,890.00
5,947.90
3,386.70
2,597.40
Capital Expenditures
235.00
243.20
582.90
1,763.60
2,060.10
Net Investing Cash Flow
235.00
363.20
582.90
1,763.60
2,060.10
Issuance/Reduction of Debt, Net
2,000.00
-
38.30
-
-
Net Financing Cash Flow
17,078.00
58.30
6,816.40
7,730.70
14.70
Net Change in Cash
13,664.00
8,194.90
285.70
2,580.40
4,642.70
Free Cash Flow
3,287.00
7,960.60
5,962.50
3,520.20
2,647.40
Net Assets from Acquisitions
-
120.00
-
-
-
Change in Capital Stock
15,084.00
20.00
6,798.30
7,690.60
-

About dorsaVi

View Profile
Address
86 Denmark Street
Kew Victoria (VIC) 3101
Australia
Employees -
Website http://www.dorsavi.com
Updated 07/08/2019
DorsaVI Pty. Ltd is a biotechnology company, which focuses on developing motion analysis device technologies for use in clinical practice, elite sports, and occupational health and safety. Its products include ViSafe, ViMove and ViPerform.